healthia
- Home
- healthia
Public
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Nonchalant PointsBet IPO commences with trading frenzy
- Review
- June 18, 2019
Latest Articles
PM encourages allied healthcare providers to stay open – Here’s three on the ASX
Amidst the national lockdown to prevent the spread of COVID-19, the government has encouraged allied healthcare providers to remain open with many of these being essential community services capable of alleviating pressure from the public health system. In his national address on Tuesday night, it was emphasised by Prime Minister Scott Morrison that “health-related servicesRead MorePublic
Healthia revenues surge 50% as Australians flock to allied health services
Allied healthcare services provider Healthia (ASX: HLA) has seen a significant growth for the first half of FY20, reporting a 50.2% rise in revenues which has also led the company to declare their maiden dividend. Compared to the corresponding H1 results for the year prior, Healthia reporting the significant jump to $44.2 million in revenueRead MorePublic
Healthia goes global, launches 3D printed orthotics lab in New York
Australian allied healthcare provider Healthia (ASX: HLA) has taken its industry-leading 3D printing technology to the world with the launch of an orthotics manufacturing lab in Astoria, New York, capable of printing 30,000 pairs annually. The new facility will be operated by iOrthotics USA, which Healthia owns a 58% stake in, and has been secured
Read MorePublic
Veterinary rollup to be taken over at 56% premium, shares skyrocket
Shareholders in National Veterinary Care (ASX: NVL) will be getting a handsome return on their investments with the veterinary services operator having received a 100% takeover offer from VetPartners to acquire all shares at $3.70 per share. The takeover offer values NVL at $251 million and represents a 56.8% premium on NVL’s closing price onRead MorePublic
Healthcare service providers poised to benefit in 2020 despite economic uncertainty
2019 has been a year like none other, with President Trump seemingly having more direct influence on international markets than any of his predecessors. It’s why we have continually seen market swings and the tiring words ‘Trade War’ repeatedly popping up in headlines on a daily basis. Under Trump’s administration, the yardstick for a President’sRead MorePublic
Investors flock to 3D-printed medtech as Osteopore shares surge 300% on opening day
Medtech company Osteopore (ASX: OSX) has had an opening day to remember having raised $5.25m through their IPO at an Offer Price of $0.20 per share, before commencing trade on the ASX today where shares reached a high of $0.80, a 300% gain. Unlike other medtech IPOs, Osteopore had already secured US FDA and CERead MorePublic
- 1
- 2